MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-03-2026
Agilent Technologies Operating Cash Flow 2011-2026 | A
Annual Operating Cash Flow Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.48 B | 921 M | 1.02 B | 1.09 B | 889 M | 793 M | 512 M | 731 M | 1.15 B | 1.23 B | 1.26 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 B | 512 M | 1.01 B |
Quarterly Operating Cash Flow Agilent Technologies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 268 M | - | - | 431 M | - | - | 485 M | - | 255 M | - | - | - | 238 M | - | 710 M | - | -59 M | 544 M | 254 M | - | 213 M | 707 M | 465 M | - | 215 M | 715 M | 518 M | - | 116 M | 601 M | 373 M | - | 111 M | 559 M | 365 M | - | -20 M | 271 M | 163 M | - | 194 M | 547 M | 519 M | - | 245 M | 775 M | 560 M | - | 150 M | 743 M | 503 M | - | 120 M | 750 M | 498 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 775 M | -59 M | 392 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 14.0 | 2.56 % | $ 99.4 M |  Israel |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
74.7 M | $ 8.91 | 0.51 % | $ 594 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 25.85 | 0.08 % | $ 718 M | USA |
 |
DexCom
DXCM
|
1.44 B | $ 67.92 | 2.38 % | $ 26.5 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 157.08 | 3.45 % | $ 7.79 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 17.51 | 1.07 % | $ 933 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | $ 103.81 | -0.04 % | $ 19.6 B | USA |
 |
Guardant Health
GH
|
-185 M | $ 87.36 | 0.2 % | $ 11 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 15.45 | 3.34 % | $ 467 M | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 17.14 | -0.87 % | $ 2.22 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 100.87 | 3.33 % | $ 8.32 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.86 | 0.7 % | $ 92.8 K | USA |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 170.64 | 3.54 % | $ 29.3 B | USA |
 |
Danaher Corporation
DHR
|
6.42 B | $ 196.09 | 2.46 % | $ 140 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
837 M | $ 120.51 | 1.03 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 199.89 | 0.48 % | $ 22.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.11 | -0.45 % | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 8.74 | 3.8 % | $ 248 M | Israel |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.31 | 2.2 % | $ 2.02 B | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 78.85 | 0.45 % | $ 5.32 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.39 | 1.84 % | $ 417 M | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 461.07 | 1.64 % | $ 13.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 224.83 | 2.14 % | $ 25.2 B |  Schweiz |
 |
Celcuity
CELC
|
-83.5 M | $ 113.19 | -1.49 % | $ 4.47 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 18.02 | 3.56 % | $ 403 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.4 | 2.0 % | $ 1.08 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-432 M | $ 201.85 | 2.11 % | $ 19.9 B | USA |
 |
OPKO Health
OPK
|
-183 M | $ 1.2 | 0.84 % | $ 833 M | USA |